SFX by Ex Libris Inc.

Title:	Actin mutations in dilated cardiomyopathy, a heritable form of heart failure
Source:	Science [0036-8075] Olson, T M yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Seidman, J G G. "The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms." Cell 104.4 (2001): 557-67.
description	2.	Finsterer, J. "Cardiogenetics, Neurogenetics, and Pathogenetics of Left Ventricular Hypertrabeculation/Noncompaction." Pediatric cardiology 30.5 (2009): 659-681.
description	3.	Olson, T. "Actin mutation in dilated cardiomyopathy, a heritable form of heart failure." Science 280.5364 (1998): 750-.
description	4.	Salazar, N.C. C. "Cardiac GPCRs: GPCR signaling in healthy and failing hearts." Biochimica et biophysica acta. Biomembranes 1768.4 (2007): 1006-1018.
description	5.	Chang, Audrey N N. "Sarcomeric protein mutations in dilated cardiomyopathy." Heart failure reviews 10.3 (2005): 225-35.
description	6.	Komajda, M. "Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy." Circulation 107.17 (2003): 2227-32.
description	7.	Fatkin, D. "Molecular mechanisms of inherited cardiomyopathies." Physiological reviews 82.4 (2002): 945-980.
description	8.	Arad, M. "Gene mutations in apical hypertrophic cardiomyopathy." Circulation 112.18 (2005): 2805-11.
description	9.	Dalkilic, I. "Muscular dystrophies: genes to pathogenesis." Current opinion in genetics & development 13.3 (2003): 231-238.
description	10.	Squire, E P M. "A new look at thin filament regulation in vertebrate skeletal muscle." The FASEB journal 12.10 (1998): 761-771.
description	11.	Yi, Xian Ping P. "Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure." The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology 282.1 (2005): 13-23.
description	12.	Hoshijima, M. "Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies." Annals of the New York Academy of Sciences 1015.1 (2004): 320-331.
description	13.	Fischmeister, R. "Compartmentation of cyclic nucleotide signaling in the heart - The role of cyclic nucleotide phosphodiesterases." Circulation research 99.8 (2006): 816-828.
description	14.	Moric-Janiszewska, G. "Genetic Heterogeneity of Left-ventricular Noncompaction Cardiomyopathy." Clinical cardiology 31.5 (2007): 201-204.
description	15.	Crespo-Leiro, M. "Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations." The American journal of cardiology 94.1 (2004): 50-4.
description	16.	Finsterer, J. "Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation." Acta neurologica Scandinavica 116.1 (2007): 1-14.
description	17.	Hernandez, Olga M., Olga M M. "F110I and R278C Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy Affect Muscle Contraction in Transgenic Mice and Reconstituted Human Cardiac Fibers." The Journal of biological chemistry 280.44 (2005): 37183-37194.
description	18.	Vang, S. "Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation." The FEBS journal 272.8 (2005): 2037-49.
description	19.	Willems, L.. "Contractile effects of adenosine, coronary flow and perfusion pressure in murine myocardium." Pflügers Archiv 453.4 (2007): 433-441.
description	20.	Massarelli, E. "KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer." Clinical cancer research 13.10 (2007): 2890-6.